Surrozen Q4 EPS $(20.13) Misses $(1.08) Estimate, Sales $500.000K Inline
3/23/2026
Impact: -80
Healthcare
Surrozen (NASDAQ: SRZN) reported Q4 losses of $(20.13) per share, significantly missing the analyst estimate of $(1.08) by 1755.3%. This represents a 133.53% increase in losses compared to $(8.62) per share in the same quarter last year. The company achieved quarterly sales of $500,000, which aligned with analyst expectations.
AI summary, not financial advice
Share: